Abstract
The H2O2-triggered prodrug activation represents a hot topic while the low H2O2 level of cancer cells hindered the complete activation of parent drugs and resulted in the poor therapeutic effect. Here, we developed an H2O2 amplifier fabricated by cross-linked lipoic acid nanocapsules (cLANCs), which would selectively elevate the intracellular H2O2 level of cancer cells 3.4-fold higher than that of untreated cancer cells so as to speed up the activation of parent drug from the loaded prodrugs (Pro-5-FU). The cytotoxicity showed that the killing effect of Pro-5-FU loaded in cLANCs (Pro-5-FU@cLANCs) arrived up to 1.6-time higher than that of Pro-5-FU alone against A549 cells, and was even close to free 5-FU. The in vivo anticancer evaluation gave the tumor inhibition rate (TIR) and survival rate (SR) of Pro-5-FU@cLANCs against A549 tumor-bearing nude mice up to 73.1% and 80%, respectively, much higher than those of Pro-5-FU (TIR: 41.2%, SR: 20%) or free 5-FU (TIR: 50.6%, SR: 0%). This nanodrug constructed the first example that utilizes the drug carriers as H2O2 amplifier to strengthen the prodrug activation.
Similar content being viewed by others
References
Rautio J, Kumpulainen H, Heimbach T, Oliyai R, Oh D, Järvinen T, Savolainen J. Nat Rev Drug Discov, 2008, 7: 255–270
Rautio J, Meanwell NA, Di L, Hageman MJ. Nat Rev Drug Discov, 2018, 17: 559–587
Sinhababu AK, Thakker DR. Adv Drug Deliver Rev, 1996, 19: 241–273
Ding C, Chen C, Zeng X, Chen H, Zhao Y. ACS Nano, 2022, 16: 13513–13553
Zhang L, Zhu L, Tang L, Xie J, Gao Y, Yu C, Shang K, Han H, Liu C, Lu Y. Adv Sci, 2023, 10: 2205246
Seidi F, Zhong Y, Xiao H, Jin Y, Crespy D. Chem Soc Rev, 2022, 51: 6652–6703
Jeon I, Yang S, Shim M, Kim K. Nano Today, 2020, 32: 100851
Wang P, Gong Q, Hu J, Li X, Zhang X. J Med Chem, 2020, 64: 298–325
Xiang J, Liu J, Liu X, Zhou Q, Zhao Z, Piao Y, Shao S, Zhou Z, Tang J, Shen Y. J Control Release, 2022, 348: 444–455
Ye H, Zhou Y, Liu X, Chen Y, Duan S, Zhu R, Liu Y, Yin L. Biomacromolecules, 2019, 20: 2441–2463
Xu X, Saw PE, Tao W, Li Y, Ji X, Bhasin S, Liu Y, Ayyash D, Rasmussen J, Huo M, Shi J, Farokhzad OC. Adv Mater, 2019, 29: 1700141
Shim MS, Xia Y. Angew Chem, 2013, 125: 7064–7067
Jo S, Kim HS, Won M, Champanhac C, Kim JS, Wurm FR, Landfester K. Adv Funct Mater, 2022, 32: 2200791
Wang S, Wang Z, Yu G, Zhou Z, Jacobson O, Liu Y, Ma Y, Zhang F, Chen ZY, Chen X. Adv Sci, 2019, 6: 1801986
Peng S, Xiao F, Chen M, Gao H. Adv Sci, 2022, 9: 2103836
Ma N, Li Y, Xu H, Wang Z, Zhang X. J Am Chem Soc, 2010, 132: 442–443
Meng T, Han J, Zhang P, Hu J, Fu J, Yin J. Chem Sci, 2019, 10: 7156–7162
Kuang Y, Balakrishnan K, Gandhi V, Peng X. J Am Chem Soc, 2011, 133: 19278–19281
Major Jourden J, Cohen S. Angew Chem Int Ed, 2010, 122: 6947–6949
Dong C, Zhou Q, Xiang J, Liu F, Zhou Z, Shen Y. J Control Release, 2020, 321: 529–539
Kim EJ, Bhuniya S, Lee H, Kim HM, Cheong C, Maiti S, Hong KS, Kim JS. J Am Chem Soc, 2014, 136: 13888–13894
Ross SM. Holistic Nurs Pract, 2006, 20: 305–306
Suntres ZE. Pharmacol Res, 2003, 48: 85–591
Xia W, Zeng X, Han X, Liu Y, Cao Y, Yan J, Huang Y. Heart, 2013, 99: A88
Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu RM, Hagen TM. Proc Natl Acad Sci USA, 2004, 101: 3381–3386
Dörsam B, Fahrer J. Cancer Lett, 2016, 371: 12–19
Wenzel U, Nickel A, Daniel H. Apoptosis, 2005, 10: 359–368
Liao C, Dai X, Chen Y, Liu J, Yao Y, Zhang S. Adv Funct Mater, 2019, 29: 1806567
Wang L, Jing P, Tan J, Liao C, Chen Y, Yu Y, Zhang S. Biomaterials, 2021, 273: 120823
Yang F, Chen Y, Zhang J, Liao C, Zhang S. J Mater Chem B, 2021, 9: 1583–1591
Zhou X, Dai X, Tan J, Wu X, Zhou X, Liao C, Zhang S. ACS Appl Mater Interfaces, 2021, 13: 56850–56857
Li B, Liu P, Wu H, Xie X, Chen Z, Zeng F, Wu S. Biomaterials, 2017, 138: 57–68
Yan C, Guo Z, Chi W, Fu W, Abedi SAA, Liu X, Tian H, Zhu WH. Nat Commun, 2021, 12: 3869
Huang J, Wang L, Zhao P, Xiang F, Liu J, Zhang S. ACS Catal, 2018, 8: 5941–5946
Wang Z, Zhang Y, Ju E, Liu Z, Cao F, Chen Z, Qu X. Nat Commun, 2018, 9: 1–14
Lin LS, Huang T, Song J, Ou XY, Wang Z, Deng H, Tian R, Liu Y, Wang JF, Liu Y, Yu G, Zhou Z, Wang S, Niu G, Yang HH, Chen X. J Am Chem Soc, 2019, 141: 9937–9945
Zhang LL, Feng ZL, Su MX, Jiang XM, Chen X, Wang Y, Li A, Lin LG, Lu JJ. Eur J Pharmacol, 2018, 830: 17–25
Chen Y, Huang J, Zhang S, Gu Z. Chem Mater, 2017, 29: 3083–3091
Acknowledgements
This work was supported by the National Natural Science Foundation of China (22201193 and 21975165), the Innovative Research Team Program of Sichuan Province (2021JDTD0015) and the National Natural Science Foundation of Sichuan Province (2023NSFSC1691). We acknowledge the Center of Testing and Analysis, Sichuan University, for the 1H NMR and TEM measurements.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest The authors declare no conflict of interest.
Additional information
Supporting information The supporting information is available online at https://chem.scichina.com and https://link.springer.com/journal/11426. The supporting materials are published as submitted, without typesetting or editing. The responsibility for scientific accuracy and content remains entirely with the authors.
Supporting Information for
Rights and permissions
About this article
Cite this article
Tan, J., Jing, P., Xiao, X. et al. Cross-linked lipoic acid nanocapsules serve as H2O2 amplifier to strengthen the H2O2-sensitive prodrug activation. Sci. China Chem. 66, 2654–2663 (2023). https://doi.org/10.1007/s11426-022-1647-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11426-022-1647-2